Catalent
CTLT
#1737
Rank
ยฃ8.64 B
Marketcap
ยฃ47.65
Share price
0.00%
Change (1 day)
8.98%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ3.71 Billion

According to Catalent's latest financial reports the company's total debt is ยฃ3.71 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30ยฃ3.82 B10.28%
2022-06-30ยฃ3.46 B47.2%
2021-06-30ยฃ2.35 B-3.8%
2020-06-30ยฃ2.44 B5.02%
2019-06-30ยฃ2.33 B13.15%
2018-06-30ยฃ2.06 B28.85%
2017-06-30ยฃ1.59 B14.54%
2016-06-30ยฃ1.39 B16.42%
2015-06-30ยฃ1.19 B-24.32%
2014-06-30ยฃ1.58 B-10.51%
2013-06-30ยฃ1.77 B3.49%
2012-06-30ยฃ1.71 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ31.68 M-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.25 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ4.07 B 9.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ0.16 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA